Professional organizations such as the American Diabetes Association do not endorse microdosing GLP-1 medications
Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies
Alcohol is not formally contraindicated with semaglutide or tirzepatide, but clinical guidance advises caution because both affect the stomach, blood sugar, and hydration through overlapping pathways
What's Inside the Upgrade The formula combines several plant-based, clinically studied ingredients that work together: Citrus flavonoids Shown in randomized controlled trials to increase fasting GLP-1 levels and improve key blood sugar markers over time
Enhance metabolic function Helping maintain balanced blood sugar levels and energy
Combined with polypharmacy, this makes older patients on GLP-1s a particularly high-priority group for pharmacist medication review